AK
Apriliana E. R. Kartikasari
Research areas: Medicine · Oncology · Iron Metabolism and Disorders · Ovarian cancer diagnosis and treatment · Cancer Immunotherapy and Biomarkers
0000-0002-8115-4866
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
-
A Novel Blood-Based Screening Strategy for Early Detection of Ovarian Cancer Using miRNA-based Biomarkers RMIT University2026 - 2027
-
Towards Precision Medicine: Predicting PARP Inhibitor Response in Ovarian Cancer. RMIT University2026 - 2027
-
Predicting Treatment Response to Immune Checkpoint Inhibitors with a Cutting-Edge Microfluidic Device RMIT University2026 - 2027
-
Upadacitinib in addition to steroids for the initial treatment of acute severe ulcerative colitis (U-SENSE) Northern Health2026 - 2027
-
Biomarkers in Inflammatory Bowel Disease Northern Health2025 - 2028
-
Real-time monitoring of cancer cell growth using microwave technology RMIT University2023 - 2023
-
Accelerating translational outcomes based on super-responders from the SOLACE2 trial of immunotherapy priming in ovarian cancer Victorian Government2022 - 2024
-
Enabling early ovarian cancer diagnosis and prediction of platinum resistance NHMRC2022 - 2025
-
Beta cell reprogramming from stem cells Hemsley Foundation2013 - 2015
-
Iron and Malaria: The Central Role of Hepcidin and Macrophage Function Foundation for NIH2009 - 2012
-
Epigenetic mechanisms in stem cell differentiation to endoderm. Role: Principal Investigator California Institute for Regenerative Medicine2009 - 2011
-
Unravelling the signaling pathways involved in the regulation of the iron hormone hepcidin European Molecular Biology Organization2007 - 2008
-
Nutrient Iron Toxicity European Commission2001 - 2005
Publications (45)
- Biomarkers for Gynaecological Cancers Save
- Tuneable one-step PEG–silane functionalisation strategy for controlled DNA probe immobilisation and enhanced hybridisation on silicon photonic biosensors Save
- Provisional Patent: 546700PRV - Enabling early ovarian cancer diagnosis Save
- Editorial: Unraveling breast cancer complexity: insights from single-cell sequencing and spatial transcriptomics Save
- HCMV as an Oncomodulatory Virus in Ovarian Cancer: Implications of Viral Strain Heterogeneity, Immunomodulation, and Inflammation on the Tumour Microenvironment and Ovarian Cancer Progression Save
- Patent Pending: 542723PCT - Predicting responders to cancer therapy Save
- IGSF11-Mediated Immune Modulation: Unlocking a Novel Pathway in Emerging Cancer Immunotherapies Save
- Interleukin-6 Is a Crucial Factor in Shaping the Inflammatory Tumor Microenvironment in Ovarian Cancer and Determining Its Hot or Cold Nature with Diagnostic and Prognostic Utilities Save
- Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial Save
- Circulating microRNAs as Diagnostic Biomarkers to Detect Specific Stages of Ovarian Cancer: A Comprehensive Meta-Analysis Save
- Interleukin-6 Modulation in Ovarian Cancer Necessitates a Targeted Strategy: From the Approved to Emerging Therapies Save
- SOLACE2: A phase II randomized trial of olaparib (O) and durvalumab (D) with or without low dose cyclophosphamide (LDCy) in platinum-sensitive recurrent ovarian cancer (PSROC) Save
- Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses Save
- Elevation of circulating TNF receptor 2 in cancer: A systematic meta-analysis for its potential as a diagnostic cancer biomarker Save
- Improving PARP inhibitor efficacy in high-grade serous ovarian carcinoma: A focus on the immune system Save
- Regulatory T Cells in Ovarian Carcinogenesis and Future Therapeutic Opportunities Save
- Elevated Interleukin-6 Levels in the Circulation and Peritoneal Fluid of Patients with Ovarian Cancer as a Potential Diagnostic Biomarker: A Systematic Review and Meta-Analysis Save
- Potential Impact of Human Cytomegalovirus Infection on Immunity to Ovarian Tumours and Cancer Progression Save
- Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis Save
- Impact of age-, cancer-, and treatment-driven inflammation on T cell function and immunotherapy Save